Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteogenesis imperfecta: perspectives and opportunities.

P H Byers1

  • 1Department of Pathology, University of Washington, Seattle 98195-7470, USA. pbyers@u.washington.edu

Current Opinion in Pediatrics
|December 6, 2000
PubMed
Summary

New treatments for osteogenesis imperfecta, including bisphosphonates and growth hormone, show promise. However, further research is needed to assess their effectiveness due to limited controlled studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta.

Genetics in medicine : official journal of the American College of Medical Genetics·2015
Same author

A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers.

Clinical genetics·2014
Same author

Successful endovascular repair of acute type B aortic dissection in undiagnosed Ehlers-Danlos syndrome type IV.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2009
Same author

Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.

Journal of medical genetics·2009
Same author

The bicuspid aortic valve: an integrated phenotypic classification of leaflet morphology and aortic root shape.

Heart (British Cardiac Society)·2008
Same author

Neurological presentation of Ehlers-Danlos syndrome type IV in a family with parental mosaicism.

Clinical genetics·2003

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Osteogenesis imperfecta (OI) is a rare genetic disorder characterized by fragile bones.
  • The treatment options for OI have historically been very limited.
  • Recent advancements have introduced novel therapeutic strategies.

Purpose of the Study:

  • To review proposed new treatments for osteogenesis imperfecta.
  • To evaluate the potential benefits and limitations of these emerging therapies.

Main Methods:

  • Review of recent literature on osteogenesis imperfecta treatments.
  • Analysis of proposed therapeutic approaches including bisphosphonates, growth hormone, and bone marrow transplantation.

Main Results:

Related Experiment Videos

  • Bisphosphonates aim to reduce bone resorption.
  • Growth hormone is proposed to enhance growth and collagen production.
  • Bone marrow transplantation seeks to establish functional collagen-producing cells.

Conclusions:

  • While new treatments offer optimism for osteogenesis imperfecta management, robust clinical evidence is lacking.
  • The absence of well-controlled studies and defined therapeutic objectives impedes a clear assessment of efficacy.
  • Further research is crucial to validate these interventions for OI patients.